New myeloma treatment options show promise

New multiple myeloma treatment options appear promising for patients aged 65 years and younger and for newly diagnosed patients who are ineligible for stem-cell transplantation, according to two studies published in the Sept. 4 issue of the New England Journal of Medicine .

http://ift.tt/1t5uoWu